BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9210682)

  • 1. Differential intracellular efficacies of ciprofloxacin and cefixime against Neisseria gonorrhoeae in human fallopian tube organ culture.
    Phanucharas JP; Gorby GL
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1547-51. PubMed ID: 9210682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing resistance to ciprofloxacin and other antibiotics in Neisseria gonorrhoeae from East Java and Papua, Indonesia, in 2004 - implications for treatment.
    Sutrisna A; Soebjakto O; Wignall FS; Kaul S; Limnios EA; Ray S; Nguyen NL; Tapsall JW
    Int J STD AIDS; 2006 Dec; 17(12):810-2. PubMed ID: 17212856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of attachment factors (pili plus Opa) on Neisseria gonorrhoeae invasion of human fallopian tube tissue in vitro: quantitation by computerized image analysis.
    Gorby GL; Schaefer GB
    Microb Pathog; 1992 Aug; 13(2):93-108. PubMed ID: 1360614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelines.
    Jones RN; Gerlach EH; Koontz FP; Murray PR; Pfaller MA; Washington JA; Erwin ME; Knapp CC
    Diagn Microbiol Infect Dis; 1991; 14(5):383-8. PubMed ID: 1797455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex bead suspension array for screening Neisseria gonorrhoeae antibiotic resistance genetic determinants in noncultured clinical samples.
    Balashov S; Mordechai E; Adelson ME; Gygax SE
    J Mol Diagn; 2013 Jan; 15(1):116-29. PubMed ID: 23159594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe.
    Cole MJ; Spiteri G; Town K; Unemo M; Hoffmann S; Chisholm SA; Amato-Gauci AJ; van de Laar M; Ison CA;
    Sex Transm Dis; 2014 Dec; 41(12):723-9. PubMed ID: 25581808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens.
    Bowie WR; Shaw CE; Chan DG; Boyd J; Black WA
    Antimicrob Agents Chemother; 1986 Oct; 30(4):590-3. PubMed ID: 3098163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
    Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
    Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
    Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.
    Wang SA; Lee MV; O'Connor N; Iverson CJ; Ohye RG; Whiticar PM; Hale JA; Trees DL; Knapp JS; Effler PV; Weinstock HS
    Clin Infect Dis; 2003 Sep; 37(6):849-52. PubMed ID: 12955650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16.
    Bazzo ML; Golfetto L; Gaspar PC; Pires AF; Ramos MC; Franchini M; Ferreira WA; Unemo M; Benzaken AS;
    J Antimicrob Chemother; 2018 Jul; 73(7):1854-1861. PubMed ID: 29635367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance in Neisseria gonorrhoeae in Finland, 1976 to 1995. The Finnish Study Group For Antimicrobial Resistance.
    Nissinen A; Järvinen H; Liimatainen O; Jahkola M; Huovinen P
    Sex Transm Dis; 1997 Nov; 24(10):576-81. PubMed ID: 9383846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines.
    Aplasca De Los Reyes MR; Pato-Mesola V; Klausner JD; Manalastas R; Wi T; Tuazon CU; Dallabetta G; Whittington WL; Holmes KK
    Clin Infect Dis; 2001 May; 32(9):1313-8. PubMed ID: 11303266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of human chorionic gonadotropin (hCG) on Neisseria gonorrhoeae invasion of and IgA secretion by human fallopian tube mucosa.
    Gorby GL; Clemens CM; Barley LR; McGee ZA
    Microb Pathog; 1991 May; 10(5):373-84. PubMed ID: 1753877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 1 Pharmacokinetic and Safety Study of Extended-Duration, High-dose Cefixime for Cephalosporin-resistant Neisseria gonorrhoeae in the Pharynx.
    Barbee LA; Nayak SU; Blumer JL; OʼRiordan MA; Gray W; Zenilman JM; Golden MR; Griffiss JM
    Sex Transm Dis; 2018 Oct; 45(10):677-683. PubMed ID: 29624558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.
    Foerster S; Unemo M; Hathaway LJ; Low N; Althaus CL
    BMC Microbiol; 2016 Sep; 16():216. PubMed ID: 27639378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
    Jiang FX; Lan Q; Le WJ; Su XH
    BMC Infect Dis; 2017 May; 17(1):366. PubMed ID: 28545411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time required for elimination of Neisseria gonorrhoeae from the urogenital tract in men with symptomatic urethritis: comparison of oral and intramuscular single-dose therapy.
    Haizlip J; Isbey SF; Hamilton HA; Jerse AE; Leone PA; Davis RH; Cohen MS
    Sex Transm Dis; 1995; 22(3):145-8. PubMed ID: 7652655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytopathic effects of the pathogenic Neisseria. Studies using human fallopian tube organ cultures and human nasopharyngeal organ cultures.
    Stephens DS; McGee ZA; Cooper MD
    Antonie Van Leeuwenhoek; 1987; 53(6):575-84. PubMed ID: 3130794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.